Clinical Trials
23 trialsNCT03023631 2026-05-20
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
NCT07590648 2026-05-15
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
Phase 4 Not yet recruiting
NCT04745910 2026-05-06
Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
M.D. Anderson Cancer Center
Phase 4 Completed
NCT04673175 2026-01-21
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Weill Medical College of Cornell University
Phase 4 Terminated
NCT04296305 2025-12-26
Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
NCT04952766 2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4 Completed
NCT03844360 2025-03-30
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Shandong University
Phase 4 Recruiting
NCT06582186 2024-09-03
VORIPRECI
University Hospital, Grenoble
Phase 4 Not yet recruiting
NCT05061654 2023-08-14
CEF-10
Hamad Medical Corporation
Phase 4 Withdrawn
NCT04738955 2021-02-04
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
Shandong Provincial Hospital
Phase 4 Unknown
NCT03649334 2020-09-09
Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy
Mansoura University
Phase 4 Completed
NCT03908138 2019-11-29
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
Shandong Provincial Hospital
Phase 4 Unknown
NCT02149329 2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4 Completed
NCT02895529 2019-05-06
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
Xian-Janssen Pharmaceutical Ltd.
Phase 4 Terminated
NCT00361140 2017-03-03
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
H. Lee Moffitt Cancer Center and Research Institute
Phase 4 Completed
NCT02576327 2016-12-30
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT02880709 2016-08-29
The Effect of Special Diets in Hematological Cancer Patients
University of Copenhagen
Phase 4 Completed
NCT01416025 2016-08-18
VoriTDM
Johns Hopkins University
Phase 4 Completed
NCT02372357 2015-03-03
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Universitaire Ziekenhuizen KU Leuven
Phase 4 Completed
NCT00500578 2012-08-01
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
M.D. Anderson Cancer Center
Phase 4 Completed
NCT01198236 2011-10-14
Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection
Zhejiang University
Phase 4 Completed
NCT00838019 2009-02-06
Intrabone Cord Blood Transplantation
Hospital Clinic of Barcelona
Phase 4 Unknown
NCT00067730 2007-12-07
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
Eli Lilly and Company
Phase 4 Completed